MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vladu, B.
Right arrow Articles by Wadkins, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vladu, B.
Right arrow Articles by Wadkins, R. M.

Vol. 57, Issue 2, 243-251, February 2000

7- and 10-Substituted Camptothecins: Dependence of Topoisomerase I-DNA Cleavable Complex Formation and Stability on the 7- and 10-Substituents

Bogdan Vladu, Jan M. Woynarowski, Govindarajan Manikumar, Mansukhlal C. Wani, Monroe E. Wall, Daniel D. Von Hoff, and Randy M. Wadkins

Cancer Therapy & Research Center, Institute for Drug Development, San Antonio, Texas (B.V., J.M.W., D.D.V.H., R.M.W.); and Research Triangle Institute, Research Triangle Park, North Carolina (G.M., M.C.W., M.E.W.).

7-Alkyl, 7-alkyl-10-hydroxy, 7-alkyl-10-methoxy, and 7-alkyl-10,11-methylenedioxy analogs of camptothecin have been synthesized and evaluated for their ability to trap human DNA topoisomerase I in cleavable complexes. The 7-alkyl chain lengths varied linearly from methyl to butyl. The concentration required to produce cleavable complexes with purified topoisomerase I in 50% of the plasmid DNA (EC50) was reduced by 1 order of magnitude by the introduction of a 10-methoxy or 7-alkyl group compared with camptothecin. The EC50 values were reduced by 2 orders of magnitude with a 10-hydroxy or 10,11-methylenedioxy moiety compared with camptothecin. The steady-state EC50 concentrations for all of the analogs tested were slightly dependent on substitution at the 7-position, but this dependence was least with the 10-methoxy series. The kinetics of the reversibility of the complexes formed with all analogs was only slightly influenced by the length of the 7-substitution, with the trend that ethyl or greater lengths led to slightly reduced rate constants for cleavable complex reversal. These results were also observed for DNA-protein cross-link formation by the analogs in isolated CEM cell nuclei. Our data indicate that in vitro cleavable complex stability, as determined by the apparent rate constants for complex dissociation, does not reflect the in vitro biological activity of these camptothecin analogs. However, complex stability in vivo may be important for the antitumor activity of the compounds.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. J. Baker, G. Wuenschell, L. Xia, J. Termini, S. E. Bates, A. D. Riggs, and T. R. O'Connor
Nucleotide Excision Repair Eliminates Unique DNA-Protein Cross-links from Mammalian Cells
J. Biol. Chem., August 3, 2007; 282(31): 22592 - 22604.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Huang, H. Gao, Y. Chen, H. Zhu, Y. Cai, X. Zhang, Z. Miao, H. Jiang, J. Zhang, H. Shen, et al.
Chimmitecan, a Novel 9-Substituted Camptothecin, with Improved Anticancer Pharmacologic Profiles In vitro and In vivo
Clin. Cancer Res., February 15, 2007; 13(4): 1298 - 1307.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
P. Luo, Q. He, X. He, Y. Hu, W. Lu, Y. Cheng, and B. Yang
Potent antitumor activity of 10-methoxy-9-nitrocamptothecin.
Mol. Cancer Ther., April 1, 2006; 5(4): 962 - 968.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. M. Wadkins, D. Bearss, G. Manikumar, M. C. Wani, M. E. Wall, and D. D. Von Hoff
Hydrophilic Camptothecin Analogs That Form Extremely Stable Cleavable Complexes with DNA and Topoisomerase I
Cancer Res., September 15, 2004; 64(18): 6679 - 6683.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. J. Loos, J. Verweij, D. F. S. Kehrer, P. de Bruijn, F. M. H. de Groot, M. Hamilton, K. Nooter, G. Stoter, and A. Sparreboom
Structural Identification and Biological Activity of 7-Methyl-10,11-Ethylenedioxy-20(S)-Camptothecin, a Photodegradant of Lurtotecan
Clin. Cancer Res., March 1, 2002; 8(3): 856 - 862.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics